Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2018-06-12 (7 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: HORNOY-LE-BOURG (80640), Somme
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SELURL PHARMACIE DOINEL : revenue, balance sheet and financial ratios
SELURL PHARMACIE DOINEL is a French company
founded 7 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in HORNOY-LE-BOURG (80640),
this company of category PME
shows in 2023 a revenue of 1.6 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELURL PHARMACIE DOINEL (SIREN 840277743)
Indicator
2025
2024
2023
2022
2021
2020
2019
Revenue
N/C
N/C
1 587 757 €
N/C
N/C
N/C
N/C
Net income
120 519 €
132 811 €
109 641 €
174 945 €
126 818 €
124 862 €
94 009 €
EBITDA
N/C
N/C
155 600 €
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
6.9%
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, SELURL PHARMACIE DOINEL generates positive net income of 121 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2019-2025: 94 k€ -> 121 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
120 519 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 37%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 68%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
37.247%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
68.251%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2019
2020
2021
2022
2023
2024
2025
Debt ratio
537.418
297.638
187.45
114.681
82.187
56.063
37.247
Financial autonomy
14.525
23.223
32.417
43.272
51.982
59.548
68.251
Repayment capacity
None
None
None
None
4.803
None
None
Cash flow / Revenue
None%
None%
None%
None%
7.301%
None%
None%
Sector positioning
Debt ratio
37.252025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Good-12 pts over 3 years
In 2025, the debt ratio of SELURL PHARMACIE DOINEL (37.25) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
68.25%2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Good+15 pts over 3 years
In 2025, the financial autonomy of SELURL PHARMACIE DOINEL (68.2%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Repayment capacity
4.8 years2023
2023
Q1: 0.95 years
Med: 3.59 years
Q3: 7.48 years
Average
In 2023, the repayment capacity of SELURL PHARMACIE DOINEL (4.80) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 348.92. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
206.647
222.496
262.962
313.649
386.257
323.279
348.924
Interest coverage
None
None
None
None
6.514
None
None
Sector positioning
Liquidity ratio
348.922025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Excellent
In 2025, the liquidity ratio of SELURL PHARMACIE DOINEL (348.92) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Interest coverage
6.51x2023
2023
Q1: 0.38x
Med: 2.71x
Q3: 6.47x
Excellent
In 2023, the interest coverage of SELURL PHARMACIE DOINEL (6.5x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution SELURL PHARMACIE DOINEL
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2019
2020
2021
2022
2023
2024
2025
Operating WCR
0 €
0 €
0 €
0 €
193 579 €
0 €
0 €
Inventory turnover (days)
0
0
0
0
19
0
0
Customer payment term (days)
0
0
0
0
5
0
0
Supplier payment term (days)
0
0
0
0
13
0
0
Positioning of SELURL PHARMACIE DOINEL in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of SELURL PHARMACIE DOINEL is estimated at
1 914 458 €
(range 1 299 160€ - 3 004 049€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
1299k€1914k€3004k€
1 914 458 €Range: 1 299 160€ - 3 004 049€
NAF 5 année 2025
Valuation method used
Net Income Multiple
120 519 €
×
15.9x
=1 914 459 €
Range: 1 299 161€ - 3 004 049€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELURL PHARMACIE DOINEL with other companies in the same sector:
Frequently asked questions about SELURL PHARMACIE DOINEL
What is the revenue of SELURL PHARMACIE DOINEL ?
The revenue of SELURL PHARMACIE DOINEL in 2023 is 1.6 M€.
Is SELURL PHARMACIE DOINEL profitable?
Yes, SELURL PHARMACIE DOINEL generated a net profit of 121 k€ in 2025.
Where is the headquarters of SELURL PHARMACIE DOINEL ?
The headquarters of SELURL PHARMACIE DOINEL is located in HORNOY-LE-BOURG (80640), in the department Somme.
Where to find the tax return of SELURL PHARMACIE DOINEL ?
The tax return of SELURL PHARMACIE DOINEL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELURL PHARMACIE DOINEL operate?
SELURL PHARMACIE DOINEL operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart